Abstract
The results are reported of a randomized prospective clinical trial carried out to assess the value of specific active immunotherapy using irradiated autologous tumour cells in patients with glioblastoma multiforme treated by radical surgery and post-operative irradiation. The results in 62 patients show no statistically significant difference in survival between the group receiving adjuvant autologous tumour cells and those treated with surgery and radiotherapy alone. All 27 patients receiving tumour cells were dead at 30 months, whereas 7 of the 35 controls were alive at this time. The results were considered sufficiently discouraging to abandon the trial at this stage on the grounds that there was sufficient evidence in this study that the administration of irradiated autologous cells was of no benefit to patients with high grade astrocytomata.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Bloom, H., Peckham, M., Richardson, A. et al. Glioblastoma Multiforme: A Controlled Trial to Assess the Value of Specific Active Immunotherapy in Patients Treated by Radical Surgery and Radiotherapy. Br J Cancer 27, 253–267 (1973). https://doi.org/10.1038/bjc.1973.30
Issue Date:
DOI: https://doi.org/10.1038/bjc.1973.30
This article is cited by
-
An integrative view on sex differences in brain tumors
Cellular and Molecular Life Sciences (2015)
-
Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model
Cancer Immunology, Immunotherapy (2006)
-
Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells
Child's Nervous System (2005)
-
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors
Cancer Immunology Immunotherapy (1995)